Schedule 13G ownership disclosure
SATSUMA PHARMACEUTICALS INC
Security class unavailable · CUSIP: 80405P107
Event date: 2019-09-13
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 5.1000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000919574-19-006510
- Form type
- SC 13G
- Filer
- CAXTON CORP
- CIK
- CIK 1388551
- Filed
- Oct 21, 2019
- Reporting period
- Sep 13, 2019
- Description
- Schedule 13G beneficial ownership